CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Estefanía Moreno

OPENALEX: A5056422298↗ORCID: 0000-0002-2491-5753↗

Affiliations

Organizations

Biomedical Research Networking Center on Neurodegenerative Diseasesauthorship · ES Centro de Investigación Biomédica en Redauthorship · ES Institut de Biomedicina de la Universitat de Barcelonaauthorship Institute for Research in Biomedicineauthorship · ES Instituto de Salud Carlos IIIauthorship · ES Universitat de Barcelonaauthorship · ES

Public evidence

4 connected articles

The CB<sub>1</sub> receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls.2024 · Europe PMC Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.2021 · PubMed Central Open Access Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects.2021 · Europe PMC Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors2015 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Estefanía Moreno - Medical Cannabis Research Engine